These beneficial metabolic effects seemed to be associated with enhanced macrophage ferroptosis, suggesting a mechanistic link between Gpx4 deficiency, ferroptosis, and the alleviation of obesity‐associated insulin resistance. The gene discussed is GPX4; the disease is obesity disorder.